Table 2.
Drug resistance pattern of studied patients (n = 80)
| Variable | Patients n (%) |
|---|---|
| Resistance to FLD | |
| Names | |
| Resistance to HR | 7 (8.8) |
| Resistance to HRE | 6 (7.5) |
| Resistance to HRES | 19 (23.8) |
| Resistance to HRESZ | 10 (12.5) |
| Resistance to HRS | 10 (12.5) |
| Resistance to HRZ | 1 (1.3) |
| Resistance to HRZS | 1 (1.3) |
| Resistance to HREZ | 3 (3.8) |
| Results unavailable* | 23 (28.8) |
| Numbers | |
| 2 | 7 (8.8) |
| 3 | 17 (21.3) |
| 4 | 23 (28.8) |
| 5 | 10 (12.5) |
| Results unavailable* | 23 (28.8) |
| Resistance to SLD | 33 (41.3) |
| Names | |
| Resistance to Ofx | 31 (38.7) |
| Resistance to Eto | 1 (1.3) |
| Resistance to Km | 1 (1.3) |
| Resistance to Ofx + Z | 1 (1.3) † |
| Resistance to Ofx + Eto | 1 (1.3) † |
| Results unavailable* | 47 (58.7) |
| Numbers | |
| 1 | 31 (38.7) |
| 2 | 2 (2.6) |
| Results unavailable | 47 (58.7) |
* Results were not documented due to one of the following reasons: drug susceptibility testing results awaited, culture contamination, no growth of culture, leakage of sample during transportation and no sputum production by the patients
† of the 31 Ofx-resistant patients
E = Ethambutol; Eto = Ethionamide; FLD = First Line Drugs; H = Isoniazid; Km = Kanamycin; Ofx = Ofloxacin; R = Rifampicin; S = Streptomycin; SLD = Second Line Drugs; Z = Pyrazinamide